Text Version
Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby
Related Resources
Order Documents
NLM
Gateway
TOXNET
Consumer
Health
Clinical Alerts
ClinicalTrials.gov
PubMed
Central
Privacy Policy
|
 |
-
Thrombotic
thrombocytopenic purpura-hemolytic uremic syndrome after bupropion
treatment for smoking cessation.
Mele L, Voso MT,
Fianchi L, Leone G, Pagano L.
Instituto di Ematologia,
Universita Cattolica del Sacro Cuore, Rome, Italy.
lumele@hotmail.com
Bupropion hydrochloride is an effective drug
for people who want stop smoking, and its use has recently increased in
many countries. The main side effects of this drug are related to its
dopaminergic activity and are dose dependent. To date, no cases of
thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS)
have been reported in literature. Here we describe a case of a woman who
developed a sporadic form of TTP-HUS during a treatment with bupropion
for smoking cessation, successfully treated with plasma ex-change
therapy. The authors wish to make readers aware of bupropion as a
possible cause of this potentially lethal disease. Copyright 2003
Lippincott Williams & Wilkins
Publication Types:
PMID: 12544732 [PubMed - indexed for
MEDLINE]
|